Guardant Health (GH) Competitors

Natera (NASDAQ:NTRA) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership, community ranking and risk.

Do insiders and institutionals have more ownership in NTRA or GH?

99.9% of Natera shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 7.6% of Natera shares are owned by company insiders. Comparatively, 5.5% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the MarketBeat Community favor NTRA or GH?

Natera received 194 more outperform votes than Guardant Health when rated by MarketBeat users. However, 71.22% of users gave Guardant Health an outperform vote while only 68.96% of users gave Natera an outperform vote.

Company	Underperform	Outperform
Natera	Outperform Votes 491 68.96%	Underperform Votes 221 31.04%
Guardant Health	Outperform Votes 297 71.22%	Underperform Votes 120 28.78%

Does the media prefer NTRA or GH?

In the previous week, Natera had 1 more articles in the media than Guardant Health. MarketBeat recorded 25 mentions for Natera and 24 mentions for Guardant Health. Natera's average media sentiment score of 1.28 beat Guardant Health's score of 0.79 indicating that Natera is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	17 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	8 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, NTRA or GH?

Natera has a beta of 1.8, suggesting that its stock price is 80% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500.

Do analysts rate NTRA or GH?

Natera presently has a consensus target price of $175.76, suggesting a potential upside of 18.40%. Guardant Health has a consensus target price of $49.00, suggesting a potential upside of 8.50%. Given Natera's higher possible upside, equities research analysts plainly believe Natera is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	3.00
Guardant Health	0 Sell rating(s)	0 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	3.05

Is NTRA or GH more profitable?

Natera has a net margin of -14.01% compared to Guardant Health's net margin of -59.05%. Natera's return on equity of -26.23% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-14.01%	-26.23%	-14.27%
Guardant Health	-59.05%	-19,157.20%	-25.96%

Which has stronger valuation and earnings, NTRA or GH?

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$1.70B	11.83	-$434.80M	-$1.53	-97.03
Guardant Health	$739.02M	7.54	-$479.45M	-$3.56	-12.69

Summary

Natera beats Guardant Health on 14 of the 19 factors compared between the two stocks.